Literature DB >> 30224651

Mutations in RECQL are not associated with breast cancer risk in an Australian population.

Na Li1,2,3, Simone M Rowley1, David L Goode3,4, Kaushalya C Amarasinghe3,5, Simone McInerny6, Lisa Devereux1,7, Michelle W Wong-Brown8,9, Richard Lupat5, Jue Er Amanda Lee1, Siobhan Hughes1, Ella R Thompson1,3,10, Magnus Zethoven5, Jason Li3,5, Alison H Trainer1,6,11, Kylie L Gorringe1,3,11, Rodney J Scott8,9,12, Paul A James1,3,6,11, Ian G Campbell13,14,15.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30224651     DOI： 10.1038/s41588-018-0206-9

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  9 in total

1.  Combined Tumor Sequencing and Case-Control Analyses of RAD51C in Breast Cancer.

Authors:  Na Li; Simone McInerny; Magnus Zethoven; Dane Cheasley; Belle W X Lim; Simone M Rowley; Lisa Devereux; Norah Grewal; Somayeh Ahmadloo; David Byrne; Jue Er Amanda Lee; Jason Li; Stephen B Fox; Thomas John; Yoland Antill; Kylie L Gorringe; Paul A James; Ian G Campbell
Journal:  J Natl Cancer Inst       Date:  2019-12-01       Impact factor: 13.506

Review 2.  RecQ Helicase Somatic Alterations in Cancer.

Authors:  Megha K Thakkar; Jamie Lee; Stefan Meyer; Vivian Y Chang
Journal:  Front Mol Biosci       Date:  2022-06-15

3.  High Expression of RECQL Protein in ER-Positive Breast Tumours Is Associated With a Better Survival.

Authors:  Ardalan Mahmoodi; Ahmed Shoqafi; Ping Sun; Vasily Giannakeas; Cezary Cybulski; Sharon Nofech-Mozes; Jean-Yves Masson; Sudha Sharma; Amir Abbas Samani; Srinivasan Madhusudan; Steven A Narod; Mohammad R Akbari
Journal:  Front Oncol       Date:  2022-05-31       Impact factor: 5.738

4.  Evaluation of the association of heterozygous germline variants in NTHL1 with breast cancer predisposition: an international multi-center study of 47,180 subjects.

Authors:  Paul A James; Ian G Campbell; Na Li; Magnus Zethoven; Simone McInerny; Lisa Devereux; Yu-Kuan Huang; Niko Thio; Dane Cheasley; Sara Gutiérrez-Enríquez; Alejandro Moles-Fernández; Orland Diez; Tu Nguyen-Dumont; Melissa C Southey; John L Hopper; Jacques Simard; Martine Dumont; Penny Soucy; Alfons Meindl; Rita Schmutzler; Marjanka K Schmidt; Muriel A Adank; Irene L Andrulis; Eric Hahnen; Christoph Engel; Fabienne Lesueur; Elodie Girard; Susan L Neuhausen; Elad Ziv; Jamie Allen; Douglas F Easton; Rodney J Scott; Kylie L Gorringe
Journal:  NPJ Breast Cancer       Date:  2021-05-12

5.  Enrichment of heterozygous germline RECQL4 loss-of-function variants in pediatric osteosarcoma.

Authors:  Kim E Nichols; Chimene A Kesserwan; Jamie L Maciaszek; Ninad Oak; Wenan Chen; Kayla V Hamilton; Rose B McGee; Regina Nuccio; Roya Mostafavi; Stacy Hines-Dowell; Lynn Harrison; Leslie Taylor; Elsie L Gerhardt; Annastasia Ouma; Michael N Edmonson; Aman Patel; Joy Nakitandwe; Alberto S Pappo; Elizabeth M Azzato; Sheila A Shurtleff; David W Ellison; James R Downing; Melissa M Hudson; Leslie L Robison; Victor Santana; Scott Newman; Jinghui Zhang; Zhaoming Wang; Gang Wu
Journal:  Cold Spring Harb Mol Case Stud       Date:  2019-10-23

6.  Prevalence of RECQL germline variants in Pakistani early-onset and familial breast cancer patients.

Authors:  Muhammad Usman Rashid; Noor Muhammad; Faiz Ali Khan; Umara Shehzad; Humaira Naeemi; Naila Malkani; Ute Hamann
Journal:  Hered Cancer Clin Pract       Date:  2020-12-20       Impact factor: 2.857

7.  RECON syndrome is a genome instability disorder caused by mutations in the DNA helicase RECQL1.

Authors:  Bassam Abu-Libdeh; Satpal S Jhujh; Srijita Dhar; Joshua A Sommers; Arindam Datta; Gabriel Mc Longo; Laura J Grange; John J Reynolds; Sophie L Cooke; Gavin S McNee; Robert Hollingworth; Beth L Woodward; Anil N Ganesh; Stephen J Smerdon; Claudia M Nicolae; Karina Durlacher-Betzer; Vered Molho-Pessach; Abdulsalam Abu-Libdeh; Vardiella Meiner; George-Lucian Moldovan; Vassilis Roukos; Tamar Harel; Robert M Brosh; Grant S Stewart
Journal:  J Clin Invest       Date:  2022-03-01       Impact factor: 14.808

8.  The TP53 mutation rate differs in breast cancers that arise in women with high or low mammographic density.

Authors:  Kylie L Gorringe; Ian G Campbell; Dane Cheasley; Lisa Devereux; Siobhan Hughes; Carolyn Nickson; Pietro Procopio; Grant Lee; Na Li; Vicki Pridmore; Kenneth Elder; G Bruce Mann; Tanjina Kader; Simone M Rowley; Stephen B Fox; David Byrne; Hugo Saunders; Kenji M Fujihara; Belle Lim
Journal:  NPJ Breast Cancer       Date:  2020-08-07

Review 9.  RECQ1 Helicase in Genomic Stability and Cancer.

Authors:  Subrata Debnath; Sudha Sharma
Journal:  Genes (Basel)       Date:  2020-06-05       Impact factor: 4.096
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.